Docetaxel as part of first-line chemotherapy for gastric cancer Editorial

  

Author:	Kelsen, D.
Title:	Docetaxel as part of first-line chemotherapy for gastric cancer
Keywords:	cancer chemotherapy; overall survival; cisplatin; fluorouracil; drug efficacy; drug safety; systemic therapy; note; capecitabine; cancer staging; progression free survival; docetaxel; drug mechanism; early diagnosis; folinic acid; stomach cancer; platinum; trastuzumab; oxaliplatin; rectum cancer; chemoradiotherapy; pyrimidine; gastrointestinal cancer; programmed death 1 ligand 1; metastatic melanoma; first-line treatment; immune checkpoint inhibitor; human; article; durvalumab; zolbetuximab
Journal Title:	Lancet Oncology
Volume:	26
Issue:	6
ISSN:	1470-2045
Publisher:	Elsevier Science, Inc.
Date Published:	2025-06-01
Start Page:	669
End Page:	671
Language:	English
DOI:	10.1016/s1470-2045(25)00154-8
PUBMED:	40286810
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-105003263972&doi=10.1016%2fS1470-2045%2825%2900154-8&partnerID=40&md5=b9345b4b11a249f7d9a74c51019817be
Notes:	Note -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/226528